Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Norchim is a French Contract Development and Manufacturing Organization (CDMO) specializing in the custom synthesis of fine chemicals and Active Pharmaceutical Ingredients (APIs). Founded in 1989 and based in Saint-Thégonnec, the company provides a comprehensive range of services from laboratory-scale R&D and process development to industrial-scale production. Norchim focuses on small molecule chemistry, offering particular expertise in complex multi-step synthesis and the production of high-value intermediates. Since 2014, it has operated as a key subsidiary of the Axyntis Group, strengthening its position within the European pharmaceutical supply chain. The company's facilities are GMP-compliant, supporting the development and manufacture of both clinical-stage candidates and commercial drug products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Norchim.